. 2019 Dec;7(23):757. doi: 10.21037/atm.2019.11.95

Table 5. Comparison of vasopressin drug use, lung complications and lengths of hospital stay between the PEEP₅ and PEEP_EIT groups.

Group	Vasopressor (yes/no)	Lung complications (yes/no)	Hospital stay (days)
PEEP₅	21/29 (42%)	17/50 (34%)	5.33±2.13
PEEP_EIT	24/26 (48%)	15/50 (30%)	6.00±2.97
P	0.55	0.67	0.21

Table 5. Comparison of vasopressin drug use, lung complications and lengths of hospital stay between the PEEP5 and PEEPEIT groups.